Novocure Ltd.
(NASDAQ : NVCR)

( )
NVCR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.68%109.630.6%$525.14m
TMOThermo Fisher Scientific Inc.
0.87%297.531.0%$389.25m
ABTAbbott Laboratories
-1.12%84.260.8%$333.53m
ISRGIntuitive Surgical, Inc.
0.02%523.222.4%$312.16m
BDXBecton, Dickinson and Company
-0.57%260.671.1%$233.40m
ALGNAlign Technology, Inc.
1.63%177.476.3%$208.70m
EWEdwards Lifesciences Corporation
-0.43%219.511.2%$208.01m
BSXBoston Scientific Corporation
-0.99%41.821.1%$192.19m
SYKStryker Corporation
-0.94%217.981.3%$189.38m
BAXBaxter International Inc.
-1.05%86.901.7%$177.58m
PODDInsulet Corporation
-0.89%143.246.9%$155.20m
DXCMDexCom, Inc.
-0.61%146.268.3%$137.20m
ZBHZimmer Biomet Holdings, Inc.
-2.68%138.791.7%$126.21m
WATWaters Corporation
-0.29%232.114.0%$110.71m
COOCooper Companies, Inc.
-1.12%301.582.2%$101.20m

Company Profile

Novocure Ltd. is global oncology company, which engages in the development and commercialization of its innovative therapy. It focuses on the commercial adoption of Optune, and its Tumor Treating Fields delivery system, for the treatment of glioblastoma (GBM), and to advance programs testing the efficacy and safety of Optune in multiple solid tumor indications through clinical pipeline. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.